Lysophosphatidic Acid Type 2 Receptor Agonists in Targeted Drug Development Offer Broad Therapeutic Potential
Journal of Lipid Research - United States
doi 10.1194/jlr.s091744
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2019
Authors
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)